Medical Technologies: Pharmaceutical Cosmetology, Cosmeceuticals – Opportunities and Limitations

Вікторія Шаповалова; Аліна Осінцева; Валентин Шаповалов

doi:10.5281/zenodo.18887719

Автор(и)

Вікторія Шаповалова Private Scientific Institution “Scientific and Research University of Medical and Pharmaceutical Law", Україна https://orcid.org/0000-0003-4770-7292
Аліна Осінцева Lviv Medical University, Україна https://orcid.org/0000-0003-1655-318X
Валентин Шаповалов Private Scientific Institution “Scientific and Research University of Medical and Pharmaceutical Law”, Україна https://orcid.org/0000-0002-9329-0195

DOI:

https://doi.org/10.5281/zenodo.18887719

Ключові слова:

medical technologies, pharmaceutical cosmetology, cosmeceuticals, cosmeceutical active ingredients, regulatory status

Анотація

Introduction. Pharmaceutical cosmetology is an interdisciplinary field at the junction of pharmacy, dermatology, and aesthetic medicine. The active development of cosmeceuticals is associated with the growing demand for products that combine a cosmetic effect with a biological effect on the skin. At the same time, the lack of a single regulatory status and mandatory randomized clinical trials creates several scientific and legal challenges. Purpose. To analyze the possibilities and limitations of cosmeceuticals in pharmaceutical cosmetology from the standpoint of modern medical technologies, evidence-based medicine, and pharmaceutical care. Methods. A systematic literature review was conducted using the PRISMA protocol using the PubMed, Scopus, Web of Science and Cochrane Library databases for 2015–2026. Out of 1243 publications, 62 sources with evidence levels I–II according to the Oxford Centre for Evidence-Based Medicine were selected after screening. Results. The article summarizes modern technological platforms of cosmeceuticals, including nanoemulsions, liposomes, multiple emulsions, and probiotic complexes, which increase the bioavailability of active ingredients by 3-5 times. The main groups of cosmeceutical active ingredients and their clinical efficacy in photoaging, acne, hyperpigmentation and alopecia are systematized. The importance of pharmaceutical care and consulting algorithms for increasing the safety of cosmeceutical use is shown. The prospects for personalized cosmeceuticals based on genetic tests and artificial intelligence are identified. Regulatory gaps in the USA, EU and Ukraine are outlined. Conclusions. Cosmeceuticals are a promising direction of integration of pharmacy, dermatology, and digital technologies, which demonstrates proven effectiveness in mild forms of dermatoses and prevention of photoaging. Further development requires standardization of the term, development of national regulatory approaches and implementation of pharmacovigilance systems.

Посилання

Crespi O., Rosset F., Pala V. et al. Cosmeceuticals for anti-aging: mechanisms, clinical evidence, and regulatory insights - a comprehensive review. Cosmetics. 2025. Vol.12. Iss.5. P.209. DOI: https://doi.org/10.3390/cosmetics12050209

Sivamani R., Jagdeo J., Elsner P., Maibach H. Cosmeceuticals. Drugs Cosmet Ind. 1985. Vol.136. Iss.4. P.51-52. URL: https://rudiapt.wordpress.com/wp-content/uploads/2017/11/cosmeceuticals-and-active-cosmetics-3rd-ed-2016.pdf

Kligman D. Cosmeceuticals. Dermatol Clin. 2000. Vol.18. Iss.4. P.609-615. DOI: https://doi.org/10.1016/S0733-8635(05)70211-4

Koo E., Kimball A., Wanner M. Cosmeceuticals. Wiley Online Library. 2016. DOI: https://doi.org/10.1002/9781118441213.rtd0157

El-Aziz A.A. Cosmeceuticals in Skin Aging. Cosmetics. 2025. Vol.12. Iss.5. P.209. DOI: https://doi.org/10.3390/cosmetics12050209

Cosmeceuticals Market Size, Share & Trends Analysis Report. 2023. URL: https://www.arizton.com/market-reports/cosmeceuticals-market-size-share

Newburger A.E. Cosmeceuticals: myths and misconceptions. Clin Dermatol. 2009. Vol.27. Iss.5. P.446-452. DOI: https://doi.org/10.1016/j.clindermatol.2009.05.008

FDA. Cosmeceutical. 2022. URL: https://www.fda.gov/cosmetics/cosmetics-labeling-claims/cosmeceutical

Regulation (EC) No 1223/2009 on cosmetic products. 2025. URL: http://data.europa.eu/eli/reg/2009/1223/oj

Electronic notification system for cosmetic products. URL: https://moz.gov.ua/uk/sistema-elektronnoyi-notifikaciyi-nadannya-informaciyi-pro-kosmetichnu-produkciyu

Resolution of the Cabinet of Ministers of Ukraine No. 65 On Approval of the Technical Regulations on Cosmetic Products. 2021. URL: https://zakon.rada.gov.ua/laws/show/65-2021-%D0%BF#Text

Page M.J. PRISMA 2020 explanation and elaboration. BMJ. 2021. No.372. P.n160. DOI: https://doi.org/10.1136/bmj.n160

Moher D. Preferred reporting items for systematic reviews and meta-analyses: PRISMA statement. PLoS Med. 2009. Vol.6. Iss.7. P.e1000097. DOI: https://doi.org/10.1371/journal.pmed.1000097

Oxford Centre for Evidence-Based Medicine. Levels of Evidence. 2009. URL: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009

Eccleston E., Gillian O. Functions of mixed emulsifiers and emulsifying waxes in dermatological lotions and creams. Colloids and Surfaces A. 1997. URL: https://www.academia.edu/116333169/Functions_of_mixed_emulsifiers_and_emulsifying_waxes_in_dermatological_lotions_and_creams

Aswathanarayan J., Vittal R. Nano-emulsions: their potential in food industry. Trends Food Sci Technol. 2012. Vol.28. Iss.2. P.132-144. DOI: https://doi.org/10.3389/fsufs.2019.00095

Choi S.J., McClements D.J. Nanoemulsions as delivery systems for lipophilic nutraceuticals. Food Sci Biotechnol. 2020. Vol.29. Iss.2. P.149-168. DOI: https://doi.org/10.1007/s10068-019-00731-4

Zylberberg C., Matosevic S. Pharmaceutical liposomal drug delivery. Drug Deliv. 2016. Vol.23. Iss.9. P.3319-3329. DOI: https://doi.org/10.1080/10717544.2016.1177136

ISO 22716 Cosmetics Good Manufacturing Practices. URL: https://www.iso.org/standard/36437.html

ICH Q1A(R2) Stability testing of new drug substances. 2003. URL: https://www.ema.europa.eu/en/ich-q1a-r2-stability-testing-new-drug-substances-drug-products-scientific-guideline

FDA. Modernization of Cosmetics Regulation Act (MoCRA). 2022. URL: https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra

Draelos Z.D. Cosmeceuticals: undefined, unclassified, and unregulated. Clin Dermatol. 2009. Vol.27. Iss.5. P.431–434. DOI: https://doi.org/10.1016/j.clindermatol.2009.05.005

Puizina-Ivić N. Skin aging. Acta Dermatovenerol Alp Pannonica Adriat. 2008. Vol.17. Iss.2. P.47–54. URL: https://pubmed.ncbi.nlm.nih.gov/18709289/

Mukherjee S., Date A., Patravale V. et al. Retinoids in the treatment of skin aging. Clin Interv Aging. 2006. Vol.1. Iss.4. P.327-348. DOI: https://doi.org/10.2147/ciia.2006.1.4.327

Lupo M.P., Cole A.L. Cosmeceutical peptides. Dermatol Ther. 2007. Vol.20. Iss.5. P.343–349. DOI: https://doi.org/10.1111/j.1529-8019.2007.00148.x

Pullar J.M., Carr A.C., Vissers M.M. The Roles of Vitamin C in skin health. Nutrients. 2017. Vol.9. Iss.8. P.866. DOI: https://doi.org/10.3390/nu9080866

França K. Topical Probiotics in dermatological therapy and skincare. Dermatol Ther. 2021. Vol.11. Iss.1. P.71-77. DOI: https://doi.org/10.1007/s13555-020-00476-7

Malaniuk K. Scalp microbiome as a key factor in hair growth. Annals of Mechnikov’s Institute. 2025. Iss.3. P.47-54. DOI: https://doi.org/10.5281/zenodo.17106246

Kornhauser A., Coelho S.G., Hearing V.J. Effects of cosmetic formulations containing hydroxyacids on sun-exposed skin. Dermatol Res Pract. 2012. P.710893. DOI: https://doi.org/10.1155/2012/710893

Antonara L., Triantafyllopoulou E., Chountoulesi M. et al. Lipid-based drug delivery systems. Nanomaterials. 2025. Vol.15. Iss.17. P.1326. DOI: https://doi.org/10.3390/nano15171326

Tiwari N., Osorio-Blanco E.R., Sonzogni A. et al. Nanocarriers for skin applications. Angew Chem Int Ed Engl. 2022. Vol.61. Iss.3. P.e202107960. DOI: https://doi.org/10.1002/anie.202107960

Benson H.A. Transdermal drug delivery. Curr Drug Deliv. 2005. Vol.2. Iss.1. P.23-33. DOI: https://doi.org/10.2174/1567201052772915

Plugariu I.A., Bercea M., Gradinaru L.M. New gel approaches for transdermal delivery of Meloxicam. Gels. 2025. Vol.11. Iss.7. P.500. DOI: https://doi.org/10.3390/gels11070500

Arif T. Salicylic acid as a peeling agent. Clin Cosmet Investig Dermatol. 2015. Vol.8. P.455-461. DOI: https://doi.org/10.2147/CCID.S84765

Mosca S., Morrone A. Human skin pigmentation. Healthcare. 2023. Vol.11. Iss.14. P.2091. DOI: https://doi.org/10.3390/healthcare11142091

Bylka W., Znajdek-Awiżeń P., Studzińska-Sroka E. Centella asiatica in cosmetology. Postepy Dermatol Alergol. 2013. Vol.30. Iss.1. P.46-49. DOI: https://doi.org/10.5114/pdia.2013.33378

Oxford Centre for Evidence-Based Medicine. Levels of Evidence. 2009. URL: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009

Bae B.G., Park C.O., Shin H. et al. Salicylic acid peels versus Jessner's solution for acne vulgaris. Dermatol Surg. 2013. Vol.39. Iss.2. P.248-253. DOI: https://doi.org/10.1111/dsu.12018

Camillo L., Zavattaro E., Savoia P. Nicotinamide in skin health. Medicina. 2025. Vol.61. Iss.2. P.254. DOI: https://doi.org/10.3390/medicina61020254

Hakozaki T., Minwalla L., Zhuang J. The effect of niacinamide on pigmentation. Br J Dermatol. 2002. Vol.147. Iss.1. P.20-31. DOI: https://doi.org/10.1046/j.1365-2133.2002.04834.x

Kong R., Cui Y., Fisher G. et al. Effects of retinol and retinoic acid. J Cosmet Dermatol. 2016. Vol.15. Iss.1. P.49-57. DOI: https://doi.org/10.1111/jocd.12193

Safety assessment of pentapeptides in cosmetics. 2023. URL: https://www.cir-safety.org/sites/default/files/Pentapeptides.pdf

Ruiz-Maldonado R., Tamayo-Sanchez L., Orozco-Covarrubias M.L. Retinoids in pediatric dermatology. Dermatol Clin. 1998. Vol.16. Iss.3. P.553-569. DOI: https://doi.org/10.1016/s0733-8635(05)70252-7

Akarsu S., Fetil E., Yücel F. et al. Salicylic acid with clindamycin and benzoyl peroxide. J Dermatol. 2012. Vol.39. Iss.5. P.433-438. DOI: https://doi.org/10.1111/j.1346-8138.2011.01405.x

Gupta A.K., Foley K.A. 5% Minoxidil for female pattern hair loss. Skin Therapy Lett. 2014. Vol.19. Iss.6. P.5-7. URL: https://pubmed.ncbi.nlm.nih.gov/25807073/

Mohiuddin A.K. The Excellence of Pharmacy Service. Int J Clin Dev Anat. 2019. Vol.5. Iss.2. P.11-32. DOI: https://doi.org/10.11648/j.ijcda.20190502.12

Kusynová Z., van den Ham H.A., Leufkens H.G. et al. Good Pharmacy Practice roles. J Pharm Policy Pract. 2022. Vol.15. Iss.1. P.94. DOI: https://doi.org/10.1186/s40545-022-00482-4

Juncan A.M., Moisă D.G., Santini A. et al. Hyaluronic acid in cosmeceuticals. Molecules. 2021. Vol.26. Iss.15. P.4429. DOI: https://doi.org/10.3390/molecules26154429

Navarrete-Solís J., Castanedo-Cázares J.P., Torres-Álvarez B. Niacinamide vs Hydroquinone trial. Dermatol Res Pract. 2011. P.379173. DOI: https://doi.org/10.1155/2011/379173

Fivenson D.P. Nicotinamide and zinc in inflammatory skin disease. Cutis. 2006. Vol.77. Suppl.1. P.5–10. URL: https://pubmed.ncbi.nlm.nih.gov/16871773/

Dhaliwal S., Rybak I., Ellis S.R. et al. Bakuchiol and retinol trial. Br J Dermatol. 2019. Vol.180. Iss.2. P.289-296. DOI: https://doi.org/10.1111/bjd.16918

FDA MedWatch Safety Information Program. 2026. URL: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program

World Health Organization. Good Pharmacy Practice Guidelines. 2011. URL: https://www.who.int/docs/default-source/medicines/norms-and-standards/guidelines/distribution/trs961-annex8-fipwhoguidelinesgoodpharmacypractice.pdf

Lau M., Mineroff J., Wang J.Y., Jagdeo J. Cosmeceuticals for antiaging systematic review. Arch Dermatol Res. 2024. Vol.316. Iss.5. P.173. DOI: https://doi.org/10.1007/s00403-024-02908-2

Fonseca S., Amaral M.N., Reis C.P. et al. Marine natural products as cosmetic ingredients. Mar Drugs. 2023. Vol.21. Iss.3. P.170. DOI: https://doi.org/10.3390/md21030170

Haykal D., Flament F., Amar D. et al. Cosmetogenomics unveiled. Front Artif Intell. 2025. Vol.8. P.1660356. DOI: https://doi.org/10.3389/frai.2025.1660356

Markiewicz E., Idowu O.C. Personalized skincare. Clin Cosmet Investig Dermatol. 2018. Vol.11. P.161–171. DOI: https://doi.org/10.2147/CCID.S163799

Tang A.S., Wei M.L., Haemel A. et al. Artificial intelligence precision dermatology. J Invest Dermatol. 2026. DOI: https://doi.org/10.1016/j.jid.2025.10.596

Hash M.G., Forsyth A., Coleman B.A. et al. Artificial Intelligence in customized skincare. Cureus. 2025. Vol.17. Iss.4. P.e82510. DOI: https://doi.org/10.7759/cureus.82510

FDA. Is it a Cosmetic, a Drug, or Both. 2024. URL: https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap

Harmonisation status for General Texts PDG. 2025. URL: https://www.edqm.eu/en/harmonisation-status-for-general-texts-pdg

Technical document on cosmetic claims. EU Commission. 2017. URL: https://ec.europa.eu/docsroom/documents/24847

Laguna C., de la Cuadra J., Martín-González B. Allergic contact dermatitis due to cosmetics. Actas Dermosifiliogr. 2009. Vol.100. Iss.1. P.53-60. URL: https://pubmed.ncbi.nlm.nih.gov/19268112/

SCCS Opinion on Vitamin A Retinol. 2022. URL: https://health.ec.europa.eu/publications/revision-scientific-opinion-sccs157616-vitamin-retinol-retinyl-acetate-retinyl-palmitate_en

Johnson K., Kirby J., Kayse A. et al. Adherence intervention program in pharmacy. J Am Pharm Assoc. 2020. Vol.60. Iss.4. P.e70-e78. DOI: https://doi.org/10.1016/j.japh.2020.02.017

Oon H.H., Wong S.N., Aw D.C. et al. Acne management Guidelines. J Clin Aesthet Dermatol. 2019. Vol.12. Iss.7. P.34-50. URL: https://pubmed.ncbi.nlm.nih.gov/31531161/

Hochwalt A.E., Abbinante-Nissen J.M., Bohman L.C. et al. Safety assessment of tampons. Front Reprod Health. 2023. Vol.5. P.1167868. DOI: https://doi.org/10.3389/frph.2023.1167868